Repatha 140 MG/ML sureclickml

Ended Awarded Last action

Contract number
SPE2DR26FNR4T
Awardee
Awarding agency
Obligated
$69,808

Award facts

Contract value 100% obligated
$69,808.22 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a $69,808.22 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and will be completed by January 13, 2026. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Repatha (evolocumab) is a PCSK9 inhibitor indicated for cholesterol management in military and federal healthcare beneficiaries, making this pharmaceutical delivery part of the Defense Logistics Agency's ongoing medical supply chain operations.

This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031. This prime IDC vehicle enables comprehensive pharmaceutical and medical supply distribution to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The arrangement positions AmerisourceBergen as a critical vendor within the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.

Quick answers

Who was awarded contract SPE2DR26FNR4T?

SPE2DR26FNR4T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.

How much is contract SPE2DR26FNR4T worth?

The government has obligated $69,808 on SPE2DR26FNR4T.

Is contract SPE2DR26FNR4T an order under another contract?

Yes. SPE2DR26FNR4T is a delivery order under SPE2DR25D1021, an indefinite delivery contract.

Was contract SPE2DR26FNR4T competed?

The extent of competition for SPE2DR26FNR4T was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award